ZA927362B - Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis.
- Google Patents
Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis.
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA927362A1992-04-241992-04-24Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis.
ZA927362B
(en)
Quinazoline derivatives, producing and using them for the treatment of hyperproliferative diseases in a mammal, and a pharmaceutical composition containing the compounds
Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type,a process for their preparation and their use as medicaments against retroviruses
Technetium-sulfonamide complexes their use pharmaceutical agents containing the latter as well as process for the production of the complexes and agents
Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments